Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 3: 619–627. Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A et al (2012). Neural correlates of the psychedelic state as determined by fMRI ...
13.Carhart‑Harris RL,Bolstridge M,Rucker J,Day CM,Erritzoe D,Kaelen M,et al.(2016a).Psilocybin with psychological support for treatment‑resistant depression:anopen‑label feasibility study.Lancet Psychiatry 3:619‑627. 14.Carhart‑Harris RL,Kaelen M,Bolstridge M,Williams TM,Williams...
anxiety and PTSD—meaning patients do not respond to medication or therapy—has become a hot topic in the mental health field. The FDA approved a nasal spray for treatment-resistant depression (TRD) last March, which uses a derivative of the hallucinogenic ketamine called esketamine. It is the ...
4 Carhart-Harris RL, Bolstridge M, Rucker J, Day CMJ, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Tay- lor D, Pilling S, Curran VH, Nutt DJ (2016b) Psilocybin with psychological support for treatment-resistant depression: an open- label feasibility study....
L. Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Front. Pharmacol. 8, 974 (2017). Article PubMed Google Scholar Griffiths, R. R. et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in ...
Targeting the demethylase-independent activity of LSD1 is an emerging strategy for the treatment of cancers. Sehrawat et al. demonstrated that LSD1 promoted AR-independent survival in LSD1 highly expressed castration-resistant prostate cancer (CRPC) cells independent of its demethylase function [31]....
Similarly, the drug ketamine, best known as a rave drug, has also shown promise in rapidly treating medication-resistant depression, and like psychedelics, its effects persist after treatment has ended. New research shows that the way psychedelics repair the brain is very similar to ketamine’s ...
增强LSD、赛洛西宾或其他致幻剂的急性情绪效应特征的MDMA治疗.pdf,披露了一种增强致幻剂的积极效应的方法,该方法为:用神入感激发剂/放心药诱导个体的积极心理状态,向个体施用致幻剂,并增强对致幻剂的积极反应。一种包含放心药/神入感激发剂和5‑羟色胺能致幻剂的组合
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 3: 619–627. Article PubMed Google Scholar Carhart-Harris RL, Erritzoe D, Williams T, Stone JM, Reed LJ, Colasanti A et al (2012). Neural correlates of the psychedelic...
LSD Resources Written by:Holly Crawford Written By:Holly Crawford Ready to explore the frontiers of consciousness? Sign up for the Reality Bites newsletter and embark on a journey into the world of psychedelics, mindfulness, and transformation. It’s where the curious minds gather....